Comparison of Top Two Shares of the Day: DXC Technology Company (NYSE:DXC), Core Laboratories N.V. (NYSE:CLB)

DXC Technology Company (NYSE:DXC)

DXC Technology Company (NYSE:DXC) closed at $30.64 on the last trading session with an decrease of -3.65%, whereas, it previously closed at $31.8. The company has a market capitalization of $8.31 Billion. The company traded shares of 6.7 Million on the trading day while its three month average volume stands at 3.76 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of DXC Technology Company (NYSE:DXC) produced diluted EPS of -5.17. The EPS estimate for next year as estimated by analysts is at 5.74 while EPS for next quarter is estimated at 1.07. Earnings per Share growth for this year is reported at -21.1, while the analysts estimated the EPS growth for next year at 5.74% and Earnings growth for next 5 years stands at -5.33% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of DXC Technology Company (NYSE:DXC) is at 0 while the forward p/e is at 5.34. The P/S or Price to Sales ratio of DXC Technology Company (NYSE:DXC) stands at 0.41 and Price to Book or P/B for the most recent quarter stands at 0.93. The Price to Free Cash Flow ratio or P/FCF is reported at 11.68. The quick ratio and the current ratio of DXC Technology Company (NYSE:DXC) are reported at 0.9 and 0.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for DXC Technology Company (NYSE:DXC) stands at 3.9, 11.1 and 7.6 respectively

The trailing twelve month Revenue of DXC Technology Company (NYSE:DXC) is reported at 20.2 Billion with income of -1289000000. The outstanding shares of DXC Technology Company (NYSE:DXC) are 271.11 Million. The institutional Ownership of the shares of 92.1 stands at 0.80%, this figure is increased 0.45 in the last six months. The insider ownership for the shares of DXC Technology Company (NYSE:DXC) is ticked at 0.6%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for DXC Technology Company (NYSE:DXC) is the Mean Target Price estimated by the analysts which stands at 38.54. The 52 week high of DXC Technology Company (NYSE:DXC) is placed at 67.83 and 52 week low is standing at 26.02.

Performance wise the shares of DXC Technology Company (NYSE:DXC) fell down -11.52% for the week, it also fell -12.48% for the monthly performance, while for the quarter it went up -13.08%. The shares decrease -3.5% for the half year and plummeted for the Year-To-Date performance. The shares of DXC Technology Company (NYSE:DXC) shrinked -54.4% for the yearly performance.

Core Laboratories N.V. (NYSE:CLB)

Core Laboratories N.V. (NYSE:CLB) closed at $33.32 on the last trading session with an decrease of -1.86%, whereas, it previously closed at $33.95. The company has a market capitalization of $1.56 Billion. The company traded shares of 677374 on the trading day while its three month average volume stands at 699.58 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Core Laboratories N.V. (NYSE:CLB) produced diluted EPS of 2.11. The EPS estimate for next year as estimated by analysts is at 2.02 while EPS for next quarter is estimated at 0.39. Earnings per Share growth for this year is reported at -2.2, while the analysts estimated the EPS growth for next year at 2.02% and Earnings growth for next 5 years stands at 3.3% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -19.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Core Laboratories N.V. (NYSE:CLB) is at 15.83 while the forward p/e is at 16.5. The P/S or Price to Sales ratio of Core Laboratories N.V. (NYSE:CLB) stands at 2.34 and Price to Book or P/B for the most recent quarter stands at 7.77. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Core Laboratories N.V. (NYSE:CLB) are reported at 1.5 and 1.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Core Laboratories N.V. (NYSE:CLB) stands at 13.2, 55.2 and 20.9 respectively

The trailing twelve month Revenue of Core Laboratories N.V. (NYSE:CLB) is reported at 668.2 Million with income of 94.2 Million. The outstanding shares of Core Laboratories N.V. (NYSE:CLB) are 46.83 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is decreased -1.67 in the last six months. The insider ownership for the shares of Core Laboratories N.V. (NYSE:CLB) is ticked at 0.9%, the figure is rose 1.3% in the last six months.

Some other important financial aspects to be discussed here for Core Laboratories N.V. (NYSE:CLB) is the Mean Target Price estimated by the analysts which stands at 41.81. The 52 week high of Core Laboratories N.V. (NYSE:CLB) is placed at 75.63 and 52 week low is standing at 33.13.

Performance wise the shares of Core Laboratories N.V. (NYSE:CLB) fell down -8.91% for the week, it also fell -18.21% for the monthly performance, while for the quarter it went up -28.91%. The shares decrease -12.71% for the half year and plummeted for the Year-To-Date performance. The shares of Core Laboratories N.V. (NYSE:CLB) shrinked -49.5% for the yearly performance.